• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial.美国全国及地区幽门螺杆菌抗生素耐药性：来自一项临床试验的经验教训。
Gastroenterology. 2021 Jul;161(1):342-344.e1. doi: 10.1053/j.gastro.2021.03.045. Epub 2021 Mar 31.
2
Drugs for Helicobacter pylori infection.用于幽门螺杆菌感染的药物。
Med Lett Drugs Ther. 2017 Jul 17;59(1525):113-117.
3
How We Approach Difficult to Eradicate Helicobacter pylori.我们如何应对难以根除的幽门螺杆菌。
Gastroenterology. 2022 Jan;162(1):32-37. doi: 10.1053/j.gastro.2021.10.048. Epub 2021 Nov 3.
4
The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance?用于评估幽门螺杆菌治疗方案的“成绩单”：在克拉霉素耐药率高的地区，在现实世界中是否可行？
J Gastrointestin Liver Dis. 2017 Jun;26(2):203-204. doi: 10.15403/jgld.2014.1121.262.lia.
5
Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.用于根除幽门螺杆菌感染的药物治疗：综述
World J Gastroenterol. 2015 Jan 7;21(1):139-54. doi: 10.3748/wjg.v21.i1.139.
6
Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance.抗生素耐药性增加方面的幽门螺杆菌感染治疗。
Adv Clin Exp Med. 2012 Sep-Oct;21(5):671-80.
7
A Never Ending Case of Helicobacter pylori.一例没完没了的幽门螺杆菌病例。
Gastroenterology. 2020 May;158(6):1552-1553. doi: 10.1053/j.gastro.2019.11.308. Epub 2020 Jan 13.
8
Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.基于实时荧光定量PCR检测幽门螺杆菌感染及基因型耐药指导的四联疗法作为幽门螺杆菌感染功能性消化不良一线治疗的疗效
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):221-5. doi: 10.1097/MEG.0000000000000186.
9
Analysis of the Primary and Post-Treatment Antibiotic Resistance of Helicobacter pylori in the Nanjing Area.南京地区幽门螺杆菌的初始治疗及治疗后耐药性分析。
Curr Pharm Biotechnol. 2021;22(5):682-685. doi: 10.2174/1389201021666200722162613.
10
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance.从未接受治疗和已接受治疗的患者近端和远端胃中的幽门螺杆菌分离株显示出遗传变异性和不一致的抗生素耐药性。
Eur J Gastroenterol Hepatol. 2011 Jun;23(6):467-72. doi: 10.1097/MEG.0b013e328345d40f.

引用本文的文献

1
Diagnostic Testing Accuracy in a High-Prevalence Native American Population of Northern Arizona.亚利桑那州北部高患病率美洲原住民人群中的诊断测试准确性
Microorganisms. 2025 Aug 18;13(8):1920. doi: 10.3390/microorganisms13081920.
2
Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China.中国连云港地区幽门螺杆菌感染及耐药状况与危险因素分析
BMC Gastroenterol. 2025 Feb 20;25(1):96. doi: 10.1186/s12876-025-03692-7.
3
Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis.2000年至2023年世界卫生组织各区域儿童幽门螺杆菌抗生素耐药性的全球流行情况：一项系统评价和荟萃分析。
BMC Med. 2024 Dec 23;22(1):598. doi: 10.1186/s12916-024-03816-y.
4
Prevalence and resistance of in a predominantly Hispanic population.在以西班牙裔为主的人群中的患病率及耐药情况
World J Gastrointest Endosc. 2024 Sep 16;16(9):526-532. doi: 10.4253/wjge.v16.i9.526.
5
Incidence trends of gastric cancer in the United States over 2000-2020: A population-based analysis.2000 年至 2020 年美国胃癌发病率趋势：基于人群的分析。
PLoS One. 2024 Sep 25;19(9):e0310040. doi: 10.1371/journal.pone.0310040. eCollection 2024.
6
Antimicrobial Resistance and the Role of Next-Generation Sequencing.抗菌药物耐药性与新一代测序技术的作用
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):469-476.
7
Novel therapeutic regimens against : an updated systematic review.针对……的新型治疗方案：一项最新的系统评价
Front Microbiol. 2024 Jun 7;15:1418129. doi: 10.3389/fmicb.2024.1418129. eCollection 2024.
8
Culture-based susceptibility-guided tailored versus empirical concomitant therapy as first-line Helicobacter pylori treatment: A randomized clinical trial.基于培养的药敏指导下的个体化治疗与经验性联合治疗作为一线幽门螺杆菌治疗：一项随机临床试验。
United European Gastroenterol J. 2024 Sep;12(7):941-950. doi: 10.1002/ueg2.12609. Epub 2024 Jun 17.
9
Comparison of the management of Helicobacter pylori infection between the older and younger European populations.中老年人幽门螺杆菌感染管理的比较。
Sci Rep. 2023 Oct 11;13(1):17235. doi: 10.1038/s41598-023-43287-4.
10
Drug-Resistant : Diagnosis and Evidence-Based Approach.耐药性：诊断与循证方法
Diagnostics (Basel). 2023 Sep 14;13(18):2944. doi: 10.3390/diagnostics13182944.

本文引用的文献

1
Transitioning of Therapy from Trial and Error to Antimicrobial Stewardship.治疗从试错法向抗菌药物管理的转变。
Antibiotics (Basel). 2020 Oct 3;9(10):671. doi: 10.3390/antibiotics9100671.
2
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.胃癌预防的筛查和根除：台北全球共识。
Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1.
3
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.利福布丁三联疗法（RHB-105）根除幽门螺杆菌：一项双盲、随机、对照试验。
Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5.
4
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.幽门螺杆菌抗生素耐药性的流行情况：世界卫生组织区域的系统评价和荟萃分析。
Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7.
5
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.美国休斯顿幽门螺杆菌感染检测共识会议
Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6. doi: 10.1016/j.cgh.2018.03.013. Epub 2018 Mar 17.
6
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections.高剂量缓释兰索拉唑（右兰索拉唑）与阿莫西林联合治疗幽门螺杆菌感染
Helicobacter. 2014 Aug;19(4):319-22. doi: 10.1111/hel.12126. Epub 2014 Apr 3.
7
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.双重质子泵抑制剂加阿莫西林作为经验性抗幽门螺杆菌治疗：来自美国的研究。
J Gastroenterol. 2010 Aug;45(8):816-20. doi: 10.1007/s00535-010-0220-x. Epub 2010 Mar 2.
8
US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori.美国关于奥美拉唑和阿莫西林治疗幽门螺杆菌的双盲对照试验。
Aliment Pharmacol Ther. 1998 Apr;12(4):377-82. doi: 10.1046/j.1365-2036.1998.00303.x.

National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial.

作者信息

Hulten Kristina G, Lamberth Linda B, Kalfus Ira N, Graham David Y

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Clinical Development, RedHill Biopharma, Tel Aviv, Israel; M2G Consulting, New York, New York.

出版信息

Gastroenterology. 2021 Jul;161(1):342-344.e1. doi: 10.1053/j.gastro.2021.03.045. Epub 2021 Mar 31.

DOI:10.1053/j.gastro.2021.03.045
PMID:33798524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267964/
Abstract
摘要